DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Manns M, Zeuzem S, Sood A. et
al.
Reduced dose and duration of peginterferon alpha-2b
and weight-based ribavirin in European and Asian genotype 2 and
3 chronic hepatitis C patients (REDD 2/3 trial).
J
Hepatol 2009; 50: A144-
We do not assume any responsibility for the contents of the web pages of other providers.